lupus nephritis Archives -

AstraZeneca has completed the resurrection of its anifrolumab drug for systemic lupus erythematosus (SLE) after claiming FDA approval

FDA approves AZ’s anifrolumab, ending 10-year lupus drug drought

https://pharmaphorum.com/news/fda-approves-azs-anifromulab-ending-10-year-lupus-drug-drought/

GlaxoSmithKline’s Benlysta has been on the market for almost a decade, but it still has some tricks up

GSK’s Benlysta claims first FDA okay for lupus kidney damage

https://pharmaphorum.com/news/gsks-benlysta-claims-first-fda-okay-for-lupus-kidney-damage/

After being all-but written off a year ago, AstraZeneca’s anifrolumab has been reborn with new data that suggest

AZ fleshes out positive trial of revitalised lupus drug anifrolumab

https://pharmaphorum.com/news/az-fleshes-out-positive-trial-of-revitalised-lupus-drug-anifrolumab/

Trial is first ever to meet primary endpoint in disease

Aurinia scores big win in lupus nephritis trial

https://pharmaphorum.com/news/aurinia-scores-big-win-lupus-nephritis-trial/

lupus nephritis